Search Results - "Wanek, Leslie A"

Refine Results
  1. 1

    Improved Survival for Stage IV Melanoma From an Unknown Primary Site by LEE, Chris C, FARIES, Mark B, WANEK, Leslie A, MORTON, Donald L

    Published in Journal of clinical oncology (20-07-2009)
    “…PURPOSE We previously demonstrated a survival advantage for nodal metastasis of melanoma from an unknown primary (MUP) versus melanoma from a known primary…”
    Get full text
    Journal Article Conference Proceeding
  2. 2

    Improved Survival After Lymphadenectomy for Nodal Metastasis From an Unknown Primary Melanoma by LEE, Chris C, FARIES, Mark B, WANEK, Leslie A, MORTON, Donald L

    Published in Journal of clinical oncology (01-02-2008)
    “…No primary lesion is identified in 10% to 20% of patients presenting with palpable evidence of regional metastatic melanoma. Because the prognostic…”
    Get full text
    Journal Article
  3. 3

    Role of Sentinel Lymphadenectomy in Thin Invasive Cutaneous Melanomas by BLEICHER, Richard J, ESSNER, Richard, FOSHAG, Leland J, WANEK, Leslie A, MORTON, Donald L

    Published in Journal of clinical oncology (01-04-2003)
    “…Regional lymph node status is the strongest prognostic determinant in early-stage melanoma. Lymphatic mapping and sentinel lymphadenectomy (LM/SL) is standard…”
    Get full text
    Journal Article
  4. 4

    Sentinel Lymphadenectomy Does Not Increase the Incidence of In-Transit Metastases in Primary Melanoma by KANG, John C, WANEK, Leslie A, ESSNER, Richard, FANES, Mark B, FOSHAG, Leland J, MORTON, Donald L

    Published in Journal of clinical oncology (20-07-2005)
    “…Recent reports by European investigators suggest that sentinel lymphadenectomy (SLND), a mainstay of melanoma diagnosis and treatment planning, increases the…”
    Get full text
    Journal Article Conference Proceeding
  5. 5
  6. 6

    Resection and adjuvant immunotherapy for melanoma metastatic to the lung and thorax by Tafra, Lorraine, Dale, Paul S., Wanek, Leslie A., Ramming, Kenneth P., Morton, Donald L.

    “…Although melamoma that metastasizes to distant sites is generally associated with a median survival of only 6 to 8 months, certain metastatic sites including…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Earlier diagnosis of second primary melanoma confirms the benefits of patient education and routine postoperative follow‐up by DiFronzo, L. Andrew, Wanek, Leslie A., Morton, Donald L.

    Published in Cancer (15-04-2001)
    “…BACKGROUND Rising health care costs have caused providers to question the benefit of regular follow‐up after treatment for patients with early stage cutaneous…”
    Get full text
    Journal Article Conference Proceeding
  10. 10

    Is sentinel lymph node mapping indicated for isolated local and in-transit recurrent melanoma? by YAO, Katharine A, HSUEH, Eddy C, ESSNER, Richard, FOSHAG, Leland J, WANEK, Leslie A, MORTON, Donald L

    Published in Annals of surgery (01-11-2003)
    “…To determine the feasibility of sentinel lymph node mapping in local and in-transit recurrent melanoma. The accuracy of intraoperative lymphatic mapping and…”
    Get full text
    Conference Proceeding Journal Article
  11. 11

    Is adjuvant radiotherapy necessary after positive lymph node dissection in head and neck melanomas? by Shen, P, Wanek, L A, Morton, D L

    Published in Annals of surgical oncology (01-09-2000)
    “…Postoperative radiotherapy (PR) has been recommended in patients with advanced head and neck melanomas to improve regional control. This study examined the…”
    Get full text
    Journal Article
  12. 12

    Increased incidence of second primary melanoma in patients with a previous cutaneous melanoma by DiFronzo, L A, Wanek, L A, Elashoff, R, Morton, D L

    Published in Annals of surgical oncology (01-10-1999)
    “…Patients with cutaneous melanoma reportedly have an increased risk of developing second primary melanoma; however, this increased risk has not been well…”
    Get full text
    Journal Article
  13. 13

    Endogenous immune response to early- and intermediate-stage melanoma is correlated with outcomes and is independent of locoregional relapse and standard prognostic factors by Litvak, David A, Gupta, Rishab K, Yee, Reynold, Wanek, Leslie A, Ye, Wei, Morton, Donald L

    “…Standard prognostic factors, including precise staging of the regional lymph nodes, cannot accurately determine which early-stage melanomas will metastasize…”
    Get full text
    Journal Article
  14. 14

    Can surgical therapy alone achieve long-term cure of melanoma metastatic to regional nodes? by Young, Shawn E, Martinez, Steve R, Faries, Mark B, Essner, Richard, Wanek, Leslie A, Morton, Donald L

    Published in The cancer journal (Sudbury, Mass.) (01-05-2006)
    “…Anecdotal reports of melanoma recurrence 15 years after complete lymphadenectomy have led to claims that the onset of nodal metastasis invariably signals…”
    Get full text
    Journal Article
  15. 15

    Judging the therapeutic value of lymph node dissections for melanoma by Chan, Arden D, Essner, Richard, Wanek, Leslie A, Morton, Donald L

    “…Background: The management of the regional lymph nodes remains controversial for early-stage melanoma and for those patients with lymph node metastases;…”
    Get full text
    Journal Article
  16. 16

    Predictors of occult nodal metastasis in patients with thin melanoma by Faries, Mark B, Wanek, Leslie A, Elashoff, David, Wright, Byron E, Morton, Donald L

    Published in Archives of surgery (Chicago. 1960) (01-02-2010)
    “…Thin primary lesions are largely responsible for the rapid increase in melanoma incidence, making identification of appropriate candidates for nodal staging in…”
    Get more information
    Journal Article
  17. 17

    Contemporary surgical treatment of advanced-stage melanoma by Essner, Richard, Lee, Jonathan H, Wanek, Leslie A, Itakura, Hitoe, Morton, Donald L

    Published in Archives of surgery (Chicago. 1960) (01-09-2004)
    “…The clinical treatment of patients with stage IV melanoma according to criteria of the American Joint Committee on Cancer (AJCC) is controversial because the…”
    Get more information
    Journal Article
  18. 18

    Can elective lymph node dissection decrease the frequency and mortality rate of late melanoma recurrences? by Shen, P, Guenther, J M, Wanek, L A, Morton, D L

    Published in Annals of surgical oncology (01-03-2000)
    “…Although more than 90% of the morbidity and mortality from localized cutaneous melanoma occurs in the first decade after initial surgical treatment, melanoma…”
    Get full text
    Journal Article
  19. 19

    Surgical management of the groin lymph nodes in melanoma in the era of sentinel lymph node dissection by Essner, Richard, Scheri, Randall, Kavanagh, Maihgan, Torisu-Itakura, Hitoe, Wanek, Leslie A, Morton, Donald L

    Published in Archives of surgery (Chicago. 1960) (01-09-2006)
    “…Intraoperative lymphatic mapping and sentinel lymphadenectomy (LM/SL) has become an increasingly popular surgical technique for staging the regional lymph…”
    Get more information
    Journal Article
  20. 20

    Lymph node biopsy does not impair survival after therapeutic dissection for palpable melanoma metastases by Kelemen, P R, Wanek, L A, Morton, D L

    Published in Annals of surgical oncology (01-03-1999)
    “…To determine the effects of disrupting a nodal basin in patients with American Joint Committee on Cancer stage III melanoma with clinically palpable lymph…”
    Get full text
    Journal Article